O-Trimethyl GFT-505, with the CAS number 923978-25-0, is a chemical compound that belongs to a class of substances known for their potential therapeutic applications, particularly in the context of metabolic disorders. This compound is characterized by its unique molecular structure, which includes trimethyl groups that influence its solubility and reactivity. O-Trimethyl GFT-505 is often studied for its role as an agonist of specific nuclear receptors, which can modulate metabolic pathways, including lipid metabolism and glucose homeostasis. Its pharmacological properties may offer insights into the treatment of conditions such as obesity and type 2 diabetes. Additionally, the compound's stability, bioavailability, and interaction with biological systems are critical factors that researchers evaluate during preclinical and clinical studies. As with many chemical substances, safety and efficacy are paramount, necessitating thorough investigation before any potential therapeutic use.

O-Trimethyl GFT-505

923978-25-0: O-Trimethyl GFT-505, with the CAS number 923978-25-0, is a chemical compound that belongs to a class of substances known for their potential therapeutic applications, particularly in the context of metabolic disorders. This compound is characterized by its unique molecular structure, which includes trimethyl groups that influence its solubility and reactivity. O-Trimethyl GFT-505 is often studied for its role as an agonist of specific nuclear receptors, which can modulate metabolic pathways, including lipid metabolism and glucose homeostasis. Its pharmacological properties may offer insights into the treatment of conditions such as obesity and type 2 diabetes. Additionally, the compound's stability, bioavailability, and interaction with biological systems are critical factors that researchers evaluate during preclinical and clinical studies. As with many chemical substances, safety and efficacy are paramount, necessitating thorough investigation before any potential therapeutic use.

<p>Applications O-Trimethyl GFT-505 is an intermediate in synthesizing GFT-505 (G368870), which is a dual PPARα/δ agonist. Studies have shown that GFT-505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects. It may also be a potential new drug candidate for treating lipid and glucose disorders.<br>References Carious, B., et al.: Diabetes Care 36, 2923 (2013); Carious, B., et al.: Diabetes Care 34, 2008 (2011);<br></p>

CAS 923978-25-0

O-Trimethyl GFT-505

O-Trimethyl GFT-505

Ref: TR-T796005